Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
14.00
+0.07 (0.50%)
Jan 7, 2026, 3:00 PM EST - Market open
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $11.75 million as of January 7, 2026. Its market cap has increased by 286.00% in one year.
Market Cap
11.75M
Enterprise Value
8.75M
1-Year Change
286.00%
Ranking
Category
Stock Price
$14.00
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $11.75M, a decrease of -87.91%. That is a compound annual growth rate of -39.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 11.69M | -3.47% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 945.15B |
| Johnson & Johnson | 497.16B |
| AbbVie | 393.12B |
| UnitedHealth Group | 316.05B |
| AstraZeneca | 280.51B |
| Merck & Co. | 270.22B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |